SCLP — Scancell Holdings Share News
0.000.00%
- £114.16m
- £120.61m
REG - Scancell Holdings - Director/PDMR Shareholding
AnnouncementREG - Scancell Holdings - Strong Phase 2 data on iSCIB1+ in Melanoma
AnnouncementREG - AIM - AIM Notice - 21/07/2025
AnnouncementREG - Scancell Holdings - Share Option Exercise
AnnouncementREG - Scancell Hlds - Scancell initiates new arm in SCOPE Phase 2 study
AnnouncementREG - Scancell Hlds - Director Dealing
AnnouncementREG - Scancell Hlds - Partnership with NHS Cancer Vaccine Launch Pad
AnnouncementREG - Scancell Hlds - Scancell to present at 2025 AACR Annual Meeting
AnnouncementREG - Scancell Hlds - Issue of share options
AnnouncementREG - Scancell Hlds - Scancell presenting at AACR IO conference
AnnouncementREG - Scancell Hlds - Interim Results
AnnouncementREG - Scancell Hlds - Notice of Interim Results
AnnouncementREG - Scancell Hlds - Modi-1 Vaccine Achieves Early Clinical Validation
AnnouncementREG - AIM - AIM Notice - 10/12/2024
AnnouncementREG - Scancell Hlds - Result of Retail Offer and Total Voting Rights
AnnouncementREG - Scancell Hlds - Result of Placing and Subscription
AnnouncementREG - Scancell Hlds - Retail Offer for up to £1 million
AnnouncementREG - Scancell Hlds - Proposed fundraise in excess of £8.5 million
AnnouncementREG - Scancell Hlds - Second Commercial License Agreement with Genmab
Announcement